Leverage and Private Equity Communities Come Together to Raise $ 2.4 Million at 10th Annual Melanoma Leverage Fundraising Event


NEW YORK–(COMMERCIAL THREAD) – Over 750 people representing over 80 companies from the leveraged finance and private equity communities gathered at the Museum of Modern Art for the 10th Annual Leveraged Finance Fights Melanoma (LFFM) Benefit Cocktail and Cocktail Party . The event raised more than $ 2.4 million for the Melanoma Research Alliance (MRA) vital research program.

“Each year, I am proud and touched by the enthusiastic response from the community to this event,” said Jeff Rowbottom, co-founder of the event. “When Brendan Dillon and I started discussing it over a decade ago, we didn’t realize it would end up bringing together so many people to support each other and have such a big impact on the breakthroughs patients have. facing melanoma in desperate need. ”

LFFM funding supports cutting-edge melanoma research that has helped patients with all types of cancer live longer and more fully. The first treatments developed specifically for melanoma are now used to treat patients with more than 12 other types of cancer.

LFFM was founded in 2011 by Jeff Rowbottom of Iron Park Capital and Brendan Dillon of UBS, both melanoma survivors. Since its founding, the LFFM has raised more than $ 16 million for the MRA, the largest nonprofit funder of melanoma research. The MRA has accelerated the pace of scientific discovery by directly investing more than $ 131 million through 380 research grants since its launch in 2007.

LFFM 2021 was co-chaired by Clare Bailhé (MidCap Financial), Brendan Dillon (UBS), Kerry Dolan (Brinley Partners), Lee Grinberg (Elliott Management), George Mueller (KKR), AJ Murphy (40North), Geoff Oltmans (Silver Lake) ), Jeff Rowbottom (Iron Park Capital), Ian Schuman (Latham & Watkins), Cade Thompson (KKR), Trevor Watt (Hellman & Friedman) and Eric Wedel (Kirkland & Ellis).

The main sponsors of the event included Kirkland & Ellis, Latham & Watkins, Iron Park Capital, Simpson Thacher & Bartlett LLP, Veritas Capital Management LLC and White & Case LLP. A full list of sponsors by level is included below.

“With the support of the leveraged finance and private equity communities, we have made unprecedented strides in achieving our mission to end the suffering and death of melanoma,” said Michael Kaplan, President and CEO of MRA. “We are not there yet, but with the support of LFFM and our other donors, we are making significant progress. ”

About the Melanoma Research Alliance (ARM)

As the largest nonprofit funder of melanoma research, MRA has committed over $ 131 million and leveraged an additional $ 415 million in collaborative and follow-up funding to achieve its mission. MRA has championed revolutions in immunotherapy, targeted therapies, new combinations and diagnostics. Thanks to the continued support of its founders, 100 percent of donations to MRA go directly to its melanoma research program. MRA’s ability to fund large-scale melanoma research is amplified through unique collaborations and partnerships with individuals, private foundations and businesses. Visit http://www.CureMelanoma.org for more information.

LFFM 2021 Sponsors


Kirkland and Ellis

Latham and Watkins

Capital of the iron park

Simpson Thacher & Bartlett LLP

Veritas Capital Management LLC

White & Case LLP


HPS Investment Partners, LLC

Fitch reviews

Allen & Overy

Bloomberg LP

BMO Capital Markets

Goldman Sachs

Shearman & Sterling LLP

Sidley Austin LLP

UBS Financial


MidCap Financial

Bank of America Merrill Lynch

Block communications

Cahill Gordon & Reindel LLP

Davis Polk & Wardwell

Lee Grinberg and Jennifer Corwin

General Atlantic Service Company, LP

Capital of Golub

Hellman & Friedman

JPMorgan Chase & Co.

King & Spalding srl


Nancy & Howard Marks

Milbank LLP

MJR Foundation

Morgan stanley

New Mountain Financial Corporation

Rose of Proskauer

Price T. Rowe

Silver Lake

Skadden, Arps, Slate, Meagher & Flom LLP

The Carlyle Group

Thomas bravo

Vista Equity Partners

Weil, Gotshal & Manges LLP

Wells Fargo Bank


Credit Suisse Asset Management / Credit Suisse


Ares Management LLC

Barclays Capital

British Columbia Partners

Blackstone Credit

Blue Owl Capital (Owl Rock Capital)

Clayton, Dubilier & Rice LLC

Cleary Gottlieb Steen & Hamilton

Cravath, Swaine & Moore LLP

Debevoise & Plimpton

Dechert srl

Brendan Dillon


Fried, Frank, Harris, Shriver & Jacobson LLP


Macquarie Group

Madison Dearborn

Mizuho Securities USA, Inc.

MJX Asset Management LLC

Oak Hill Consultants, LP

Oak Hill Capital Management

Onex Credit Partners

Ropes and gray LLP

Royal Bank of Canada / RBC Capital Markets

Roche d’Argent Financial

Capital of Stone Point

Sullivan & Cromwell LLP


Jefferies LLC

Transport throughout the country

Angelo Gordon & Co.

Capital One Bank

GoldenTree Asset Management, LP


LCD / S & P

Matt Nord and Erika Weinberg

Orchard First Source Asset Management

Paul Hastings LLP

Seix Investment Advisors

Shenkman Capital Management Inc.

Siris Capital Group, LLC

Stonepeak Partners

Warburg Pincus LLC

Source link


Leave A Reply